BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bicker J, Fortuna A, Alves G, Falcão A. Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders. Curr Pharm Des 2020;26:594-619. [PMID: 31939728 DOI: 10.2174/1381612826666200115101544] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Almasi F, Dang W, Mohammadipanah F, Li N. Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01420-3] [Reference Citation Analysis]
2 Jin Z, Han Y, Zhang D, Li Z, Jing Y, Hu B, Sun S. Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients. Pharmaceutics 2022;14:2070. [DOI: 10.3390/pharmaceutics14102070] [Reference Citation Analysis]
3 Iqubal A, Iqubal MK, Sharma S, Wasim M, Alfaleh MA, Md S, Baboota S, Ali J, Haque SE. Pathogenic mechanisms and therapeutic promise of phytochemicals and nanocarriers based drug delivery against radiotherapy-induced neurotoxic manifestations. Drug Deliv 2022;29:1492-511. [PMID: 35543534 DOI: 10.1080/10717544.2022.2064562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fortuna A, Schindowski K, Sonvico F. Editorial: Intranasal Drug Delivery: Challenges and Opportunities. Front Pharmacol 2022;13:868986. [PMID: 35308245 DOI: 10.3389/fphar.2022.868986] [Reference Citation Analysis]
5 Vaz G, Clementino A, Mitsou E, Ferrari E, Buttini F, Sissa C, Xenakis A, Sonvico F, Dora CL. In Vitro Evaluation of Curcumin- and Quercetin-Loaded Nanoemulsions for Intranasal Administration: Effect of Surface Charge and Viscosity. Pharmaceutics 2022;14:194. [PMID: 35057089 DOI: 10.3390/pharmaceutics14010194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Domin H. Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies. Prog Neuropsychopharmacol Biol Psychiatry 2021;111:110349. [PMID: 33991587 DOI: 10.1016/j.pnpbp.2021.110349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Kimura S, Harashima H. Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB. Pharmaceutics 2020;12:E1216. [PMID: 33334049 DOI: 10.3390/pharmaceutics12121216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
8 Wang Q, Xie C, Xi S, Qian F, Peng X, Huang J, Tang F. Radioprotective Effect of Flavonoids on Ionizing Radiation-Induced Brain Damage. Molecules 2020;25:E5719. [PMID: 33287417 DOI: 10.3390/molecules25235719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Yaksh TL. Frontiers in Pain Research: A Scope of Its Focus and Content. Front Pain Res 2020;1. [DOI: 10.3389/fpain.2020.601528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Khadka B, Lee JY, Park DH, Kim KT, Bae JS. The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation. Biomolecules 2020;10:E1401. [PMID: 33019651 DOI: 10.3390/biom10101401] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
11 Perioli L. Active Ingredients of Natural Sources and their Applications. Curr Pharm Des 2020;26:517-8. [PMID: 32213155 DOI: 10.2174/138161282606200306105213] [Reference Citation Analysis]